“Brodalumab Provides Rapid Onset of Therapeutic Response for Patients With Moderate-to-Severe Psoriasis”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s133. Accessed May 1, 2026. https://skin.dermsquared.com/skin/article/view/1986.